[Form 4] Vivid Seats Inc. Warrant Insider Trading Activity

Rhea-AI Filing Summary

Riva Bakal, Chief Supply/Customer Officer at Vivid Seats Inc., reported transactions on Form 4 relating to Class A common stock and restricted stock units (RSUs). On 08/12/2025 she was issued 1,233 RSUs (each convertible into one share) and simultaneously disposed of 535 Class A shares at $17.51 per share. After these transactions she beneficially owned 18,752 Class A shares including shares underlying RSUs. The filing states one-third of the RSUs vested on May 12, 2025, with the remainder vesting in equal quarterly installments to be fully vested by May 12, 2027; the RSUs have no expiration date. The reported share figures were adjusted for a 1-for-20 reverse stock split effected August 5, 2025.

Insights

Securities Analyst

TL;DR: Insider received RSUs, sold a portion of shares at $17.51; overall beneficial ownership remains material but reduced slightly.

The filing documents a standard compensation-related grant and a contemporaneous disposition. The 1,233 RSUs increase contingent holdings while the sale of 535 shares at $17.51 reduces immediately owned shares. Vesting schedule is explicit: one-third vested 05/12/2025 and remaining vest quarterly through 05/12/2027. The adjustment for a 1-for-20 reverse split on 08/05/2025 is disclosed, which affects reported share counts. This appears to be routine equity compensation and a partial sale, with no additional contractual or material event disclosed.

Corporate Governance Expert

TL;DR: Disclosure aligns with Section 16 requirements; transactions reflect compensation vesting and routine disposition, not a governance change.

The report lists the reporting person as an officer and provides required detail on RSU vesting terms and the absence of an expiration date. The filing clearly states the vesting schedule and quantifies post-transaction beneficial ownership (18,752 shares). The presence of both acquisition (RSUs) and a sale on the same date is documented and adjusted for the recent reverse split. No resignations, related-party transfers, or other governance actions are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bakal Riva

(Last) (First) (Middle)

C/O VIVID SEATS INC.

24 E. WASHINGTON ST., STE. 900

(Street)

CHICAGO IL 60602

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vivid Seats Inc. [ SEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Supply/Customer Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/12/2025		M		1,233	A	(1)	19,287	D
Class A Common Stock	08/12/2025		F		535	D	$17.51	18,752	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/12/2025		M			1,233	(2)	(2)	Class A Common Stock	1,233	$0	8,634	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. One-third of the RSUs vested on May 12, 2025. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on May 12, 2027. The RSUs do not have an expiration date.

Remarks:

The numbers of shares (including shares underlying RSUs) reported on this Form 4 have been adjusted to give effect to a 1-for-20 reverse stock split of the Issuer's Class A and Class B common stock that was effected on August 5, 2025.

	/s/ Riva Bakal	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.